10 20 30 40 50 60 70 80 3IBC - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE, APOPTOSIS 15-JUL-09 3IBC
TITLE CRYSTAL STRUCTURE OF CASPASE-7 INCOMPLEX WITH ACETYL-YVAD- TITLE 2 CHO
COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-7; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: P20 SUBUNIT; COMPND 5 SYNONYM: CASP-7, ICE-LIKE APOPTOTIC PROTEASE 3, ICE-LAP3, COMPND 6 APOPTOTIC PROTEASE MCH-3, CMH-1, CASPASE-7 SUBUNIT P20, COMPND 7 CASPASE-7 SUBUNIT P11; COMPND 8 EC: 3.4.22.60; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: CASPASE-7; COMPND 12 CHAIN: B, D; COMPND 13 FRAGMENT: P10 SUBUNIT; COMPND 14 SYNONYM: CASP-7, ICE-LIKE APOPTOTIC PROTEASE 3, ICE-LAP3, COMPND 15 APOPTOTIC PROTEASE MCH-3, CMH-1, CASPASE-7 SUBUNIT P20, COMPND 16 CASPASE-7 SUBUNIT P11; COMPND 17 EC: 3.4.22.60; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 3; COMPND 20 MOLECULE: ACETYL-YVAD-CHO; COMPND 21 CHAIN: E, F; COMPND 22 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP7, MCH3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CASP7, MCH3; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 OTHER_DETAILS: THE PEPTIDE WAS OBTAINED BY CHEMICAL SOURCE 18 SYNTHESIS.
KEYWDS PROTEIN-PEPTIDE COMPLEX, ALTERNATIVE SPLICING, APOPTOSIS, KEYWDS 2 CYTOPLASM, HYDROLASE, POLYMORPHISM, PROTEASE, THIOL KEYWDS 3 PROTEASE, ZYMOGEN
EXPDTA X-RAY DIFFRACTION
AUTHOR J.AGNISWAMY
REVDAT 2 10-NOV-09 3IBC 1 JRNL REVDAT 1 01-SEP-09 3IBC 0
JRNL AUTH J.AGNISWAMY,B.FANG,I.T.WEBER JRNL TITL CONFORMATIONAL SIMILARITY IN THE ACTIVATION OF JRNL TITL 2 CASPASE-3 AND -7 REVEALED BY THE UNLIGANDED AND JRNL TITL 3 INHIBITED STRUCTURES OF CASPASE-7. JRNL REF APOPTOSIS V. 14 1135 2009 JRNL REFN ISSN 1360-8185 JRNL PMID 19655253 JRNL DOI 10.1007/S10495-009-0388-9
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 83.5 REMARK 3 NUMBER OF REFLECTIONS : 19020 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 915 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3798 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 59 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 3IBC COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-AUG-09. REMARK 100 THE RCSB ID CODE IS RCSB054199.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI 220 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20517 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.1 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 55.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.46400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1F1J REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14.5% PEG 3350, 0.3 M DIAMMONIUM REMARK 280 HYDROGEN CITRATE, 10MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 125.43333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.71667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.71667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 125.43333 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -87.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, F, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400 REMARK 400 COMPOUND REMARK 400 THE SHORT PEPTIDE USED IN EXPERIMENT WAS ACETYL-YVAD-CHO, UPON REMARK 400 CHEMICAL REACTION, IT IS BOUND TO PROTEIN.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 24 REMARK 465 LYS A 25 REMARK 465 PRO A 26 REMARK 465 ASP A 27 REMARK 465 ARG A 28 REMARK 465 SER A 29 REMARK 465 SER A 30 REMARK 465 PHE A 31 REMARK 465 VAL A 32 REMARK 465 PRO A 33 REMARK 465 SER A 34 REMARK 465 LEU A 35 REMARK 465 PHE A 36 REMARK 465 SER A 37 REMARK 465 LYS A 38 REMARK 465 LYS A 39 REMARK 465 LYS A 40 REMARK 465 LYS A 41 REMARK 465 ASN A 42 REMARK 465 VAL A 43 REMARK 465 THR A 44 REMARK 465 MET A 45 REMARK 465 ARG A 46 REMARK 465 SER A 47 REMARK 465 ILE A 48 REMARK 465 LYS A 49 REMARK 465 THR A 50 REMARK 465 THR A 51 REMARK 465 ARG A 52 REMARK 465 ASP A 53 REMARK 465 ARG A 54 REMARK 465 VAL A 55 REMARK 465 PRO A 56 REMARK 465 ALA B 207 REMARK 465 ASN B 208 REMARK 465 PRO B 209 REMARK 465 ARG B 210 REMARK 465 TYR B 211 REMARK 465 ALA C 324 REMARK 465 LYS C 325 REMARK 465 PRO C 326 REMARK 465 ASP C 327 REMARK 465 ARG C 328 REMARK 465 SER C 329 REMARK 465 SER C 330 REMARK 465 PHE C 331 REMARK 465 VAL C 332 REMARK 465 PRO C 333 REMARK 465 SER C 334 REMARK 465 LEU C 335 REMARK 465 PHE C 336 REMARK 465 SER C 337 REMARK 465 LYS C 338 REMARK 465 LYS C 339 REMARK 465 LYS C 340 REMARK 465 LYS C 341 REMARK 465 ASN C 342 REMARK 465 VAL C 343 REMARK 465 THR C 344 REMARK 465 MET C 345 REMARK 465 ARG C 346 REMARK 465 SER C 347 REMARK 465 ILE C 348 REMARK 465 LYS C 349 REMARK 465 THR C 350 REMARK 465 THR C 351 REMARK 465 ARG C 352 REMARK 465 ASP C 353 REMARK 465 ARG C 354 REMARK 465 VAL C 355 REMARK 465 PRO C 356 REMARK 465 ALA D 507 REMARK 465 ASN D 508 REMARK 465 PRO D 509 REMARK 465 ARG D 510
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP E 705 C ASP E 705 O 0.212 REMARK 500 ASP F 805 C ASP F 805 O 0.222 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 113 75.68 35.85 REMARK 500 CYS A 136 -178.73 -173.45 REMARK 500 SER A 143 -164.33 -163.99 REMARK 500 ASN A 148 -5.15 72.95 REMARK 500 CYS A 171 77.37 -155.34 REMARK 500 PRO B 235 -13.77 -45.11 REMARK 500 GLU B 250 38.02 -71.71 REMARK 500 GLU B 251 -22.03 -159.74 REMARK 500 HIS B 252 -5.83 -148.24 REMARK 500 ARG B 271 -99.66 -89.10 REMARK 500 HIS B 272 -36.05 -17.29 REMARK 500 GLU B 274 111.78 -173.27 REMARK 500 PHE B 301 44.13 -89.77 REMARK 500 ASP C 413 69.50 34.86 REMARK 500 CYS C 436 -173.50 -172.23 REMARK 500 SER C 443 -167.36 -167.92 REMARK 500 ASN C 448 -3.73 74.54 REMARK 500 CYS C 471 67.47 -151.21 REMARK 500 PRO D 535 -19.39 -49.03 REMARK 500 ARG D 571 -109.75 -83.62 REMARK 500 HIS D 572 -54.38 0.01 REMARK 500 GLU D 574 114.73 -167.40 REMARK 500 ASP D 578 41.87 -90.53 REMARK 500 PHE D 601 44.76 -94.25 REMARK 500 SER D 602 -176.70 -173.02 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 49 DISTANCE = 6.31 ANGSTROMS
DBREF 3IBC A 24 196 UNP P55210 CASP7_HUMAN 24 196 DBREF 3IBC B 207 303 UNP P55210 CASP7_HUMAN 207 303 DBREF 3IBC C 324 496 UNP P55210 CASP7_HUMAN 24 196 DBREF 3IBC D 507 603 UNP P55210 CASP7_HUMAN 207 303 DBREF 3IBC E 701 705 PDB 3IBC 3IBC 1 5 DBREF 3IBC F 801 805 PDB 3IBC 3IBC 1 5
SEQRES 1 A 173 ALA LYS PRO ASP ARG SER SER PHE VAL PRO SER LEU PHE SEQRES 2 A 173 SER LYS LYS LYS LYS ASN VAL THR MET ARG SER ILE LYS SEQRES 3 A 173 THR THR ARG ASP ARG VAL PRO THR TYR GLN TYR ASN MET SEQRES 4 A 173 ASN PHE GLU LYS LEU GLY LYS CYS ILE ILE ILE ASN ASN SEQRES 5 A 173 LYS ASN PHE ASP LYS VAL THR GLY MET GLY VAL ARG ASN SEQRES 6 A 173 GLY THR ASP LYS ASP ALA GLU ALA LEU PHE LYS CYS PHE SEQRES 7 A 173 ARG SER LEU GLY PHE ASP VAL ILE VAL TYR ASN ASP CYS SEQRES 8 A 173 SER CYS ALA LYS MET GLN ASP LEU LEU LYS LYS ALA SER SEQRES 9 A 173 GLU GLU ASP HIS THR ASN ALA ALA CYS PHE ALA CYS ILE SEQRES 10 A 173 LEU LEU SER HIS GLY GLU GLU ASN VAL ILE TYR GLY LYS SEQRES 11 A 173 ASP GLY VAL THR PRO ILE LYS ASP LEU THR ALA HIS PHE SEQRES 12 A 173 ARG GLY ASP ARG CYS LYS THR LEU LEU GLU LYS PRO LYS SEQRES 13 A 173 LEU PHE PHE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 A 173 ASP GLY ILE GLN SEQRES 1 B 97 ALA ASN PRO ARG TYR LYS ILE PRO VAL GLU ALA ASP PHE SEQRES 2 B 97 LEU PHE ALA TYR SER THR VAL PRO GLY TYR TYR SER TRP SEQRES 3 B 97 ARG SER PRO GLY ARG GLY SER TRP PHE VAL GLN ALA LEU SEQRES 4 B 97 CYS SER ILE LEU GLU GLU HIS GLY LYS ASP LEU GLU ILE SEQRES 5 B 97 MET GLN ILE LEU THR ARG VAL ASN ASP ARG VAL ALA ARG SEQRES 6 B 97 HIS PHE GLU SER GLN SER ASP ASP PRO HIS PHE HIS GLU SEQRES 7 B 97 LYS LYS GLN ILE PRO CYS VAL VAL SER MET LEU THR LYS SEQRES 8 B 97 GLU LEU TYR PHE SER GLN SEQRES 1 C 173 ALA LYS PRO ASP ARG SER SER PHE VAL PRO SER LEU PHE SEQRES 2 C 173 SER LYS LYS LYS LYS ASN VAL THR MET ARG SER ILE LYS SEQRES 3 C 173 THR THR ARG ASP ARG VAL PRO THR TYR GLN TYR ASN MET SEQRES 4 C 173 ASN PHE GLU LYS LEU GLY LYS CYS ILE ILE ILE ASN ASN SEQRES 5 C 173 LYS ASN PHE ASP LYS VAL THR GLY MET GLY VAL ARG ASN SEQRES 6 C 173 GLY THR ASP LYS ASP ALA GLU ALA LEU PHE LYS CYS PHE SEQRES 7 C 173 ARG SER LEU GLY PHE ASP VAL ILE VAL TYR ASN ASP CYS SEQRES 8 C 173 SER CYS ALA LYS MET GLN ASP LEU LEU LYS LYS ALA SER SEQRES 9 C 173 GLU GLU ASP HIS THR ASN ALA ALA CYS PHE ALA CYS ILE SEQRES 10 C 173 LEU LEU SER HIS GLY GLU GLU ASN VAL ILE TYR GLY LYS SEQRES 11 C 173 ASP GLY VAL THR PRO ILE LYS ASP LEU THR ALA HIS PHE SEQRES 12 C 173 ARG GLY ASP ARG CYS LYS THR LEU LEU GLU LYS PRO LYS SEQRES 13 C 173 LEU PHE PHE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 C 173 ASP GLY ILE GLN SEQRES 1 D 97 ALA ASN PRO ARG TYR LYS ILE PRO VAL GLU ALA ASP PHE SEQRES 2 D 97 LEU PHE ALA TYR SER THR VAL PRO GLY TYR TYR SER TRP SEQRES 3 D 97 ARG SER PRO GLY ARG GLY SER TRP PHE VAL GLN ALA LEU SEQRES 4 D 97 CYS SER ILE LEU GLU GLU HIS GLY LYS ASP LEU GLU ILE SEQRES 5 D 97 MET GLN ILE LEU THR ARG VAL ASN ASP ARG VAL ALA ARG SEQRES 6 D 97 HIS PHE GLU SER GLN SER ASP ASP PRO HIS PHE HIS GLU SEQRES 7 D 97 LYS LYS GLN ILE PRO CYS VAL VAL SER MET LEU THR LYS SEQRES 8 D 97 GLU LEU TYR PHE SER GLN SEQRES 1 E 5 ACE TYR VAL ALA ASP SEQRES 1 F 5 ACE TYR VAL ALA ASP
HET ACE E 701 3 HET ACE F 801 3
HETNAM ACE ACETYL GROUP
FORMUL 5 ACE 2(C2 H4 O) FORMUL 7 HOH *59(H2 O)
HELIX 1 1 ASP A 79 GLY A 83 5 5 HELIX 2 2 GLY A 89 GLY A 105 1 17 HELIX 3 3 SER A 115 GLU A 128 1 14 HELIX 4 4 ILE A 159 HIS A 165 1 7 HELIX 5 5 CYS A 171 LEU A 175 5 5 HELIX 6 6 TRP B 240 GLY B 253 1 14 HELIX 7 7 GLU B 257 ARG B 271 1 15 HELIX 8 8 ASP C 379 GLY C 383 5 5 HELIX 9 9 GLY C 389 GLY C 405 1 17 HELIX 10 10 SER C 415 GLU C 429 1 15 HELIX 11 11 ILE C 459 HIS C 465 1 7 HELIX 12 12 PHE C 466 LEU C 475 5 10 HELIX 13 13 TRP D 540 GLY D 553 1 14 HELIX 14 14 GLU D 557 ARG D 571 1 15
SHEET 1 A12 PHE A 106 ASN A 112 0 SHEET 2 A12 GLY A 68 ASN A 74 1 N ASN A 74 O TYR A 111 SHEET 3 A12 PHE A 137 LEU A 142 1 O ILE A 140 N ILE A 71 SHEET 4 A12 LYS A 179 GLN A 184 1 O LEU A 180 N CYS A 139 SHEET 5 A12 PHE B 219 TYR B 223 1 O ALA B 222 N PHE A 181 SHEET 6 A12 CYS B 290 SER B 293 -1 O VAL B 292 N PHE B 221 SHEET 7 A12 CYS D 590 SER D 593 -1 O VAL D 591 N SER B 293 SHEET 8 A12 PHE D 519 TYR D 523 -1 N PHE D 521 O VAL D 592 SHEET 9 A12 LYS C 479 GLN C 484 1 N PHE C 481 O ALA D 522 SHEET 10 A12 PHE C 437 LEU C 442 1 N LEU C 441 O GLN C 484 SHEET 11 A12 GLY C 368 ASN C 374 1 N ILE C 371 O ILE C 440 SHEET 12 A12 PHE C 406 ASN C 412 1 O TYR C 411 N ASN C 374 SHEET 1 B 3 GLY A 145 GLU A 146 0 SHEET 2 B 3 VAL A 149 TYR A 151 -1 O VAL A 149 N GLU A 146 SHEET 3 B 3 VAL A 156 PRO A 158 -1 O THR A 157 N ILE A 150 SHEET 1 C 3 GLY B 238 SER B 239 0 SHEET 2 C 3 TRP B 232 SER B 234 -1 N SER B 234 O GLY B 238 SHEET 3 C 3 VAL E 703 ALA E 704 -1 O VAL E 703 N ARG B 233 SHEET 1 D 3 GLY C 445 GLU C 446 0 SHEET 2 D 3 VAL C 449 TYR C 451 -1 O VAL C 449 N GLU C 446 SHEET 3 D 3 VAL C 456 PRO C 458 -1 O THR C 457 N ILE C 450 SHEET 1 E 2 GLY C 488 GLU C 490 0 SHEET 2 E 2 GLY D 528 TYR D 529 1 O GLY D 528 N GLU C 490 SHEET 1 F 3 GLY D 538 SER D 539 0 SHEET 2 F 3 TRP D 532 SER D 534 -1 N SER D 534 O GLY D 538 SHEET 3 F 3 VAL F 803 ALA F 804 -1 O VAL F 803 N ARG D 533
LINK C ACE E 701 N TYR E 702 1555 1555 1.39 LINK C ACE F 801 N TYR F 802 1555 1555 1.38 LINK SG CYS C 486 C ASP F 805 1555 1555 1.78 LINK SG CYS A 186 C ASP E 705 1555 1555 1.79
CRYST1 88.248 88.248 188.150 90.00 90.00 120.00 P 32 2 1 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011332 0.006542 -0.000001 0.00000
SCALE2 0.000000 0.013084 -0.000001 0.00000
SCALE3 0.000000 0.000000 0.005315 0.00000